Study to Assess In-home Use of Evolocumab (AMG 145) Using a Prefilled Syringe or a Prefilled Autoinjector/Pen

NCT01849497 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

149

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Hypercholesterolemia
Mixed Dyslipidemia

Interventions

BIOLOGICAL: Evolocumab Pre-filled Syringe
BIOLOGICAL: Evolocumab AI/pen

Sponsor

Amgen